Navigation Links
PharmAthene Reports First Quarter 2009 Financial and Operational Results
Date:5/15/2009

,348,453 2,502,909 Total assets $53,723,840 $56,391,270 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $3,409,022 $3,870,871 Accrued expenses and other liabilities 12,197,532 14,624,757 Convertible notes 13,828,776 13,377,505 Current portion of warrants to purchase common stock 377,753 - Current portion of long-term debt 3,947,979 4,000,000 Total current liabilities 33,761,062 35,873,133 Other long-term liabilities 2,230,670 626,851 Warrants to purchase common stock 1,158,031 - Long-term debt - 928,117 Total liabilities 37,149,763 37,427,831 Stockholders' equity: Common stock, $0.0001 par value; 100,000,000 shares authorized; 28,012,031 and 25,890,143 shares issued and outstanding at March 31, 2009 and December 31, 2008; respectively, 2,802 2,589 Additional paid-in capital 146,662,830 142,392,163 Accumulated other comprehensive (loss) income (260,869) 386,351 Accumulated deficit (129,830,686) (123,817,664) Total stockholders' equity 16,574,077 18,963,439 Total liabilities and stockholders' equity $53,723,840 $56,391,270

                                  PHARMATHENE, INC.

                        CONSOLIDATED STATEMENTS OF OPERATIONS

                                           Three months ended March 31,
                                      
'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. PharmAthene Named as Contractor in $13.9 Million Award Notice Published by the Department of Health and Human Services
4. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
5. PharmAthene to Present at the BIO CEO & Investor Conference 2008
6. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
7. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
8. PharmAthene to Present at the Cowen and Company 28th Annual Health Care Conference
9. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
10. PharmAthene to Delay Release of Full Year 2007 Financial Results
11. PharmAthene Year-End 2007 Earnings Conference Call and Webcast Scheduled for Monday, March 31, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014  Nektar Therapeutics (NASDAQ: ... characterizing the analgesic profiles of a series of ... agonist molecules. The preclinical research candidates were created ... The analgesic properties of kappa receptor ... 1,2 Kappa opioid receptors are expressed in ...
(Date:9/19/2014)... Dublin ... announced the addition of the  "Micro Market Monitor ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... fastest-growing segments in the chromatography market. The market ... expected to reach $2.0 billion by 2019, at ...
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... near-patient testing, is performed outside a clinical laboratory. ... hence in administrating appropriate treatments and medication. POCT ... and prevalence of lifestyle diseases such as diabetes, ... and user-friendly. POCT devices are standardized to minimize ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Texas ... John Sharp, Texas A&M Health Science Center CEO ... Department of Health and Human Services (HHS), State ... a national pandemic influenza vaccine manufacturing facility in ... an anchor for the Texas A&M Biocorridor – ...
Breaking Biology Technology:Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Micro Market Monitor : Global Pre-packed Chromatography Columns 2POCT Market in China 2014-2018 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 2Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 3Texas A&M Dedicates National Pandemic Influenza Vaccine Manufacturing Facility, on Track for 2016 Start-Up Phase 4
... ... PharmSource Information Services, Inc. announces the publication of a ... How to Minimize Your Risk." This incisive resource provides guidelines on ... risk for companies doing business throughout the world. "The U.S. Foreign ...
... SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., July 7 ... Lilly and Company (NYSE: LLY ) and Alkermes, ... New Drug Application (NDA) for exenatide once weekly has been ... (FDA). , , Exenatide once weekly is an investigational ...
... Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... Sun Pharmaceutical Industries Ltd. (Sun Pharma), immediately following Sun ... Drug Administration (FDA) for its Abbreviated New Drug Application ... tablets are an androgen receptor inhibitor indicated for use ...
Cached Biology Technology:PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry 2PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry 3New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 2New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 3New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 4New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 5New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 6Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets 2
(Date:9/18/2014)... A team of researchers from McGill University and ... form of polyethylene ,microbeads, Canadian Journal of ... likely originate from cosmetics, household cleansers, or industrial ... abrasives. Owing to their small size and buoyancy, ... Microplastics are a global contaminant in the ...
(Date:9/18/2014)... DNA, tiny strands of nucleic acid that contain instructions ... genetic data, our DNA is copied into RNA molecules, ... tasks in our cells. , Several years ago, ... all other known RNAs, this molecule is circular, and ... little has been known about how they are produced. ...
(Date:9/18/2014)... from several disciplines will be celebrated tonight at the ... in improving the health of premature infants and in ... The researchers, whose work was supported by the National ... former Atomic Energy Commission, will be honored at a ... A bipartisan group of Members of Congress will be ...
Breaking Biology News(10 mins):Microplastic pollution discovered in St. Lawrence River sediments 2Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 23rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2
... that rising global temperatures accompanied by melting permafrost in ... into the atmosphere. Once released, that methane gas would ... radiation about 20 times more efficiently than does the ... appearing in the Journal of Geophysical Research ...
... that specially synthesized boron compounds are readily accepted in ... a proof of concept that could lead to new ... Oregon chemist Shih-Yuan Liu reported in the Journal ... of boron-nitrogen compounds with electronic and structural similarities to ...
... This release is available in German . ... restoration and maintenance of the Earth,s multi-trillion dollar ecosystems - ... can have a key role in countering climate change and ... of a new climate issues update by The Economics of ...
Cached Biology News:Methane gas likely spewing into the oceans through vents in sea floor 2Methane gas likely spewing into the oceans through vents in sea floor 3Boron-based compounds trick a biomedical protein 2Time to tap climate-change-combating potential of the world's ecosystems 2Time to tap climate-change-combating potential of the world's ecosystems 3Time to tap climate-change-combating potential of the world's ecosystems 4Time to tap climate-change-combating potential of the world's ecosystems 5